Which medication should be used to terminate an acute seizure in a pregnant woman?

Acute Seizure Termination in Pregnancy

Benzodiazepines (lorazepam or midazolam) are the first-line medications for terminating acute seizures in pregnancy, followed by intravenous phenytoin or fosphenytoin if seizures persist. 1, 2, 3

First-Line Treatment: Benzodiazepines

Lorazepam is the preferred initial agent when intravenous access is available, administered as a rapid IV bolus. 1, 2, 3, 4

Midazolam (intramuscular or intravenous) is equally efficacious and should be considered when IV access is difficult or delayed, particularly in pre-hospital settings. 2, 3, 4

Key Clinical Points About Benzodiazepines:

• Time to treatment is critical—clinical response diminishes with prolonged seizure activity. 4
• Both lorazepam and midazolam provide rapid seizure control with complete bioavailability. 3
• Monitor for hypotension and respiratory depression, though benefits of seizure control far outweigh these risks. 1, 3
• Good fetal outcome depends on rapid maternal seizure control, making aggressive treatment essential. 1

Second-Line Treatment: Phenytoin/Fosphenytoin

If benzodiazepines fail to control seizures, intravenous phenytoin or fosphenytoin should be administered immediately. 1, 2, 3

Fosphenytoin is preferred over phenytoin because it avoids cardiac arrhythmias, hypotension, and tissue injury at injection sites associated with phenytoin. 3

• Phenytoin/fosphenytoin was used in 72% of pregnancy-related status epilepticus cases with good maternal outcomes (79% recovery to baseline). 2
• These agents are established as effective despite being known human teratogens—uncontrolled seizures pose greater fetal risk than anticonvulsant exposure. 1, 5

Alternative Second-Line Agents

Valproic acid, levetiracetam, or lacosamide (all intravenous) may be considered, though comparative effectiveness data in pregnancy-related status epilepticus remain limited. 3

Phenobarbital is an established option for refractory seizures, though it carries sedation risks. 1, 5

Special Case: Eclampsia

For eclamptic seizures specifically, magnesium sulfate is the preferred first-line agent. 2

• However, evidence for magnesium sulfate's true anticonvulsant properties is weak, and its use may decline in favor of standard status epilepticus management with benzodiazepines and phenytoin. 1
• In all five eclampsia cases reviewed, magnesium sulfate was used first-line with good outcomes. 2

Critical Management Principles

Aggressive Treatment is Essential:

• Uncontrolled seizures pose greater risk to the fetus than anticonvulsant exposure—this is the fundamental principle guiding treatment. 1, 5
• Seizures in pregnancy must be managed as aggressively as in non-pregnant patients. 1

Common Pitfalls to Avoid:

• Do not delay treatment due to concerns about medication teratogenicity—the risks of uncontrolled seizures (maternal hypoxia, fetal hypoxia, trauma) far exceed medication risks. 1, 5
• Do not use inadequate doses—standard adult dosing protocols apply. 1
• Do not withhold phenytoin/fosphenytoin after benzodiazepines if seizures continue—early escalation improves outcomes. 1, 2

Evaluation Considerations:

• Workup for new-onset seizures in pregnancy is identical to non-pregnant patients, including head CT with appropriate abdominal shielding. 1
• The most common causes of pregnancy-related status epilepticus are posterior reversible encephalopathy syndrome (PRES)/reversible cerebral vasoconstriction syndrome (RCVS) (38%), cortical venous sinus thrombosis (17%), and autoimmune encephalitis (17%). 2

Prognosis

With early detection and appropriate treatment, pregnancy-related status epilepticus carries a good prognosis: 79% of mothers recover to baseline, and 58% of fetuses are delivered at term. 2

Up to 95% of pregnancies in women with epilepsy have favorable outcomes with proper seizure management. 5